Physician profile
Dawn M Mcgee
NPI 1043261332
$1,248.04
in general payments reported to CMS, 2019-2025
14 companies · $83.30 in 2025
The $83.30 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $59.99 · 2021: $278 · 2022: $258 · 2023: $294 · 2024: $119 · 2025: $83.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $782.46 | 2019-2025 | |
| Coopersurgical, INC. | $159.09 | 2019-2024 | Endosee, Paragard T 380a |
| Hologic Sales and Service, LLC | $48.41 | 2020-2024 | Aptima |
| Biogen, INC. | $38.44 | 2025 | Zurzuvae |
| Allergan, INC. | $37.79 | 2019 | |
| Exeltis, USA INC. | $36.28 | 2020-2021 | |
| Organon LLC | $23.69 | 2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $22.71 | 2020 | |
| Boston Scientific Corporation | $21.59 | 2019 | |
| Astellas Pharma US INC | $17.09 | 2025 | Veozah |
| Amneal Pharmaceuticals LLC | $16.86 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.65 | 2019 | |
| Avion Pharmaceuticals | $15.28 | 2021 | |
| Ascend Therapeutics US, LLC | $12.70 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.